BCR-ABL-IN-5 is a Bcr-Abl (Breakpoint cluster region-Abelson) kinase inhibitor that acts on Bcr-AblWT (IC50: 0.014 µM) and Bcr-AblT3151 (IC50: 0.45 µM) and exhibits some anti-proliferative effects on leukemic cells. effect.
Molecular Weight:
494.37
CAS Number:
[1795736-60-5]
Formula:
C25H21Cl2N5O2
Target:
Others|||Bcr-Abl
T63332
* VAT and and shipping costs not included. Errors and price changes excepted